UTI vs DAO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 17, 2026

UTI

49.6
AI Score
VS
UTI Wins

DAO

36.1
AI Score

Investment Advisor Scores

UTI

50score
Recommendation
HOLD

DAO

36score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric UTI DAO Winner
Forward P/E 35.5872 0 Tie
PEG Ratio 2.3751 0 Tie
Revenue Growth 7.2% 3.8% UTI
Earnings Growth -78.9% -50.0% DAO
Tradestie Score 49.6/100 36.1/100 UTI
Profit Margin 3.9% 1.2% UTI
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL UTI

Relative Price Performance (Last 90 Days)

UTI 1M: -42.2% · 3M: -38.9% DAO 1M: +25.2% · 3M: +58.9%

Current Technical Phase

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 26

RSI (14): 25.6 · Price: $22.35

DAO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (16.6% over 20 days), RSI 63

RSI (14): 63.0 · Price: $18.34

Fundamentals Snapshot

Metric UTI DAO
Market Cap
Forward P/E 30.4 6.4
Trailing P/E 39.5 187.3
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.6% 0.4%
Operating Margin 0.0% 0.0%
EPS 0.58 0.09
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.